⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for resectable pancreatic carcinoma

Every month we try and update this database with for resectable pancreatic carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic CancerNCT01959672
Pancreatic Aden...
Resectable Panc...
Stage I Pancrea...
Stage IA Pancre...
Stage IB Pancre...
Stage II Pancre...
Stage IIA Pancr...
Stage IIB Pancr...
Stage III Pancr...
4-Dimensional C...
Fluorouracil
Gemcitabine Hyd...
Laboratory Biom...
Leucovorin Calc...
Nelfinavir Mesy...
Oregovomab
Stereotactic Bo...
Therapeutic Con...
19 Years - University of Nebraska
Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by SurgeryNCT02427841
Pancreatic Aden...
Resectable Panc...
Fluorouracil
Gemcitabine
Image Guided Ra...
Intensity-Modul...
Laboratory Biom...
Nab-paclitaxel
Therapeutic Con...
18 Years - OHSU Knight Cancer Institute
Intravital Microscopy in Human Solid TumorsNCT03823144
Solid Tumor, Ad...
Clinical Stage ...
Gastric Carcino...
Malignant Solid...
Metastatic Colo...
Metastatic Gast...
Metastatic Prim...
Metastatic Sarc...
Postneoadjuvant...
Resectable Colo...
Resectable Live...
Resectable Panc...
Resectable Sarc...
Stage IV Colore...
Diagnostic Micr...
Fluorescein Sod...
18 Years - Mayo Clinic
Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic CancerNCT01959672
Pancreatic Aden...
Resectable Panc...
Stage I Pancrea...
Stage IA Pancre...
Stage IB Pancre...
Stage II Pancre...
Stage IIA Pancr...
Stage IIB Pancr...
Stage III Pancr...
4-Dimensional C...
Fluorouracil
Gemcitabine Hyd...
Laboratory Biom...
Leucovorin Calc...
Nelfinavir Mesy...
Oregovomab
Stereotactic Bo...
Therapeutic Con...
19 Years - University of Nebraska
Intravital Microscopy in Human Solid TumorsNCT03823144
Solid Tumor, Ad...
Clinical Stage ...
Gastric Carcino...
Malignant Solid...
Metastatic Colo...
Metastatic Gast...
Metastatic Prim...
Metastatic Sarc...
Postneoadjuvant...
Resectable Colo...
Resectable Live...
Resectable Panc...
Resectable Sarc...
Stage IV Colore...
Diagnostic Micr...
Fluorescein Sod...
18 Years - Mayo Clinic
Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic CancerNCT01959672
Pancreatic Aden...
Resectable Panc...
Stage I Pancrea...
Stage IA Pancre...
Stage IB Pancre...
Stage II Pancre...
Stage IIA Pancr...
Stage IIB Pancr...
Stage III Pancr...
4-Dimensional C...
Fluorouracil
Gemcitabine Hyd...
Laboratory Biom...
Leucovorin Calc...
Nelfinavir Mesy...
Oregovomab
Stereotactic Bo...
Therapeutic Con...
19 Years - University of Nebraska
Acupuncture for the Management of Postoperative Pain in Patients With Pancreatic or Colorectal Cancer Undergoing SurgeryNCT04560712
Resectable Colo...
Resectable Dige...
Resectable Panc...
Acupuncture The...
Best Practice
Questionnaire A...
18 Years - M.D. Anderson Cancer Center
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 MutationNCT04858334
Pancreatic Acin...
Pancreatic Aden...
Pancreatic Squa...
Resectable Panc...
Resectable Panc...
Resectable Panc...
Resectable Panc...
Biospecimen Col...
Computed Tomogr...
Magnetic Resona...
Olaparib
Placebo Adminis...
18 Years - National Cancer Institute (NCI)
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 MutationNCT04858334
Pancreatic Acin...
Pancreatic Aden...
Pancreatic Squa...
Resectable Panc...
Resectable Panc...
Resectable Panc...
Resectable Panc...
Biospecimen Col...
Computed Tomogr...
Magnetic Resona...
Olaparib
Placebo Adminis...
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: